Table 3.

Panton-Valentine Leukocidin prevalence as reported by the eligible studies with sample size of 30 or above.

Country	PVL positive (no. positive/total tested)	Prevalence (%)	References
Algeria	46/61	75	Ramdani-bouguessa et al., 2006
	19/64	30	Ouchenane et al., 2011
	94/122	77	Antri et al., 2011
Kenya	14/69	20	Maina et al., 2013
Libya	10/35	29	Al-haddad et al., 2014
Nigeria	33/70	47	Ghebremedhin et al., 2009
South Africa	1/320	0.3	Moodley et al., 2010
	4/97	4	Makgotlho et al., 2009
	5/56	9	Oosthuysen et al., 2014
Tunisia	68/72	94	Ben Nejma et al., 2006
	64/64	100	Ben Nejma et al., 2013
	43/69	62	Ben Jomàa-Jemili et al., 2013
Uganda	30/41	73	Kateete et al., 2011
Multicenter*	20/86	23	Breurec et al., 2011b

^*Multicenter study which included Cameroon, Madagascar, Morocco, Niger and Senegal.

PVL, Panton-Valentine Leukocidin; no., Number.